Jackson Square Partners LLC Cuts Stake in Align Technology, Inc. $ALGN
Jackson Square Partners LLC cut its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 40.6% during the third quarter, according to the company in its most recent filing with...
Evercore ISI upped their target price on shares of Align Technology from $180.00 to $200.00 and gave the company an "outperform" rating in a research note on Thursday...
MarketBeat·1d ago
MCK Q3 Earnings & Sales Top Estimates, 2026 View Up
McKesson beats Q3 EPS and revenue estimates, raises fiscal 2026 guidance, and delivers broad-based growth led by oncology, specialty distribution and technology.
Zacks·2d ago
Are Medical Stocks Lagging Bayer (BAYRY) This Year?
Here is how Bayer Aktiengesellschaft (BAYRY) and Align Technology (ALGN) have performed compared to their sector so far this year.
Zacks·2d ago
Here's Why Align Technology (ALGN) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·2d ago
Align Technology (NASDAQ:ALGN) Given New $185.00 Price Target at Jefferies Financial Group
Jefferies Financial Group raised their price objective on Align Technology from $155.00 to $185.00 and gave the company a "hold" rating in a report on Thursday...
MarketBeat·2d ago
QGEN's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down
QIAGEN shares decline as Q4 earnings meet estimates and revenues beat, with margin contraction and cautious 2026 guidance in focus.
Zacks·2d ago
RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand
Resmed shares rise after Q2 EPS and revenues beat expectations, with the gross and operating margins expanding sharply across core segments.
Zacks·2d ago
Deep Dive Into Align Technology Stock: Analyst Perspectives (8 Ratings)
read more...
Benzinga·3d ago
Mizuho Issues Positive Forecast for Align Technology (NASDAQ:ALGN) Stock Price
Mizuho boosted their price objective on Align Technology from $200.00 to $215.00 and gave the company an "outperform" rating in a research note on Thursday...